Abstract Details

Title Immunotherapy after Discontinuation of Natalizumab in Relapsing Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 143

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Neeta Garg, MD (Harbor UCLA Medical Center)	Dr. Garg has nothing to disclose.
Andrew Bursaw, DO	No disclosure on file
	No disclosure on file

��ɫ����